# An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder

> **NCT01038128** · NA · COMPLETED · sponsor: **Mclean Hospital** · enrollment: 5 (actual)

## Conditions studied

- Bulimia Nervosa
- Body Dysmorphic Disorder

## Interventions

- **DRUG:** Memantine

## Key facts

- **NCT ID:** NCT01038128
- **Lead sponsor:** Mclean Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2015-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01038128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01038128, "An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01038128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*